Melhores Leucemia linfoblástica aguda médicos em Israel - TOP-20 médicos

O Dr. Ram Ron trabalha em um dos maiores e principais hospitais públicos de ensino de Israel, o Sourasky Medical Center (Ichilov), conhecido por seu atendimento ao paciente de alto nível e inovação médica.

• Aceder a tratamentos e tecnologias avançadas em um hospital universitário de primeira linha
• Fazer parte de uma equipe multidisciplinar e abrangente de hematologia-oncologia
• Beneficiar-se de um centro dedicado tanto ao atendimento ao paciente quanto à pesquisa
• Trabalhar em um hospital credenciado pela Joint Commission International

O Dr. Ron Ram realizou centenas de transplantes de células-tronco, um procedimento fundamental para a leucemia linfoblástica aguda, como hematologista-oncologista certificado.

• Certificação em hematologia e oncologia médica
• Formação durante uma especialização (fellowship) em Hematologia e Oncologia no New York Medical College
• Publicação de mais de 30 artigos científicos sobre condições hematológicas
• Autor de um capítulo em um livro médico

A Dra. Ronit El Hasid realizou mais de 300 transplantes de medula óssea e de sangue do cordão umbilical em crianças no Dana Dwek Children’s Hospital.

• Chefe do Departamento de Onco-Hematologia e Oncologia Pediátrica
• Mais de 50 publicações e mais de 40 relatórios de conferências
• Membro da Associação Americana de Hematologia
• Formada no City of Hope Hospital em Los Angeles

Prof. Amos Toren, MD, PhD, MHA, is a pediatric hemato-oncologist and BMT specialist. He served as Director of Pediatric Hemato-Oncology and BMT at Sheba Medical Center.

He is board certified in Pediatrics, Pediatric Hemato-Oncology, and Bone Marrow Transplantation. He holds a PhD in Human Genetics. He was Head of the Hematology Division at Tel Aviv University for two terms. He is a member of ASH, COG, ESPHI, EBMT, and CIBMTR. He also serves on the Ministry of Health Cord Blood Committee.

He led one of Israel’s most advanced pediatric oncology and BMT programs. The program treated children and young adults. His focus includes leukemia and lymphoma, immunodeficiencies, and rare cancers. He specializes in BMT and CAR T-cell therapy.

His translational research covers CAR T cells, cytokine-induced killer cells, pediatric brain tumors, and targeted therapies. He has worked with St. Anna, the NIH, and St. Jude. His publications include studies on pediatric SCT prophylaxis and PARP resistance.

Dr. Hana Golan, MD, heads the Pediatric Hemato-Oncology and Bone Marrow Transplantation (BMT) Division at Sheba Medical Center. She specializes in childhood cancers, with a focus on neuroblastoma and other high-risk solid tumors.

She leads one of the region’s most advanced pediatric oncology programs. She manages complex, high-risk cases and practices at a hospital ranked in the global top 10.

She is the principal investigator of the High-Risk Neuroblastoma ESIOP protocol. She serves as an investigator in international Phase I/II trials and as the national coordinator of multicenter oncology protocols. She led the development of computerized chemotherapy protocols and patient databases to improve safety.

She earned her MD from the Technion. She completed residencies in pediatrics and pediatric hemato-oncology at Sheba. She conducted advanced research in transplantation immunology at the Weizmann Institute. She is board-certified in Pediatrics and Pediatric Hematology-Oncology. She is a Senior Lecturer at the Sackler Faculty of Medicine, Tel Aviv University. Her research focuses on cancer stem cells, targeted therapies, treatment-resistant malignancies, and cannabinoid-related oncology.

O Dr. Michael Shapira especializa-se exclusivamente em transplante de medula óssea no Sourasky Medical Center – líder em tratamentos hematológicos.

• Graduado pela faculdade de medicina da Universidade Hebraica em 1999
• Especializado em medicina interna no Hadassah Medical Center
• Médico sênior em Transplante de Medula Óssea no Hadassah
• Fluente em inglês e hebraico

O Dr. Fredi Aviv traz mais de 31 anos de prática focada como onco-hematologista no principal Centro Médico Sourasky de Tel Aviv.

• Especializar-se exclusivamente em cancros do sangue, como leucemia e linfoma
• Possuir longa permanência num importante hospital académico e de investigação
• Oferecer experiência profunda tanto em diagnósticos iniciais como em planos de tratamento complexos
• Proporcionar acesso às mais recentes terapias hospitalares e ensaios clínicos

O Dr. Dror Levin dirige o departamento de hematologia e oncologia pediátrica no Sourasky Medical Center em Tel Aviv, um dos principais hospitais de Israel.

• Especialista sénior no tratamento de doenças do sangue e cancro ósseo em crianças
• Formado em oncologia pediátrica no Schneider Children's Medical Center
• Especializado em hematologia pediátrica, incluindo distúrbios de coagulação em prematuros
• Estudou tratamento de sarcomas no mundialmente reconhecido Rizzoli Orthopaedic Institute
• Membro ativo da Sociedade Israelita de Hemato-Oncologia Pediátrica

O Dr. Herishanu foi reconhecido com vários prêmios de prestígio por suas pesquisas em leucemia linfocítica crônica.

• Mais de 30 anos de experiência médica como hematologista
• Autor de diversos artigos de pesquisa publicados
• Formado em hematologia no Tel Aviv Medical Center
• Membro das Associações Americana e Israelense de Hematologia

Prof. Avichai Shimoni, MD, is Director of Bone Marrow Transplantation at Sheba Medical Center. He is a hemato-oncologist with over 30 years of experience in bone marrow transplantation, cellular therapies, and advanced blood cancer care.

He leads a high-volume program for complex, high-risk blood cancers. He performs allogeneic and autologous transplants. He also provides CAR T-cell therapy for leukemia, lymphoma, and multiple myeloma. He completed a bone marrow transplantation fellowship at MD Anderson Cancer Center.

He is Chairman of Hematology at Tel Aviv University and a Professor of Hematology. He has authored more than 250 scientific papers. His research focuses on CAR T-cell therapy and stem cell transplantation. He is often listed among Israel's Best Doctors (Forbes 2025 and 2026).

Dr. Hila Magen, MD, leads the Multiple Myeloma and Amyloidosis Unit at Sheba Medical Center. She is a hemato-oncologist with over 35 years of experience. She is a leading Israeli expert in multiple myeloma and plasma cell disorders.

She runs a program that provides personalized care and early access to clinical trials. This includes CAR-T therapy for high-risk and relapsed or refractory myeloma and amyloidosis. Dr. Magen is a principal investigator in point-of-care CAR-T studies. She brings new immunotherapies into routine care.

Training: Fellowships in Multiple Myeloma (UAMS) and Lymphocytic Leukemia (MD Anderson). Academic: Instructor, Tel Aviv University. Research: Author of 100+ publications, contributor to landmark myeloma studies, and reviewer for international journals.

Dr. Abraham Avigdor, MD, is Director of the Institute of Hematology and Co‑Director of the Hematology & Bone Marrow Transplantation Division at Sheba Medical Center. He is an international leader in lymphoma, CAR‑T, and advanced hemato‑oncology with more than 35 years of experience. His clinical focus includes lymphomas, multiple myeloma, and complex blood cancers.

He is a pioneer in CAR‑T integration. He leads cellular therapy and bone marrow transplantation programs (autologous and allogeneic). He also advances stem cell therapies and precision diagnostics, including PET/CT‑based prognostics. His work includes immunotherapy and targeted regimens and the development of innovative, data‑driven protocols.

He collaborates with LYSA, EMCL, and international PET groups. He has authored more than 130 publications. Key roles include Founder and President of the Israeli Lymphoma Working Group, former Chair of the Israeli Lymphoma Study Group, and Senior Lecturer at Tel Aviv University. Education: MD, Ben‑Gurion University; residency, Sheba Medical Center; postdoctoral fellowship, Weizmann Institute. Awards include the Knesset Prize, the Israeli Ministry of Health Award, and the Sackler Prize.

Dr. Iris Kventsel, MD, is a pediatric hemato-oncologist and bone marrow transplant (BMT) specialist at Sheba Medical Center. She is an attending physician in the Pediatric Hemato-Oncology and BMT Division at the Edmond and Lily Safra Children’s Hospital. Her clinical focus is pediatric sarcomas, including Ewing sarcoma, osteosarcoma, and rhabdomyosarcoma.

She provides multidisciplinary care, including transplant and cellular therapies. She also uses current chemotherapy protocols and targeted therapies for complex childhood cancers.

Her research focuses on genetic cancer predisposition, including Li-Fraumeni syndrome, and cancer susceptibility genes. She has published in pediatric oncology, stem cell biology, and surgical oncology (HIPEC). She is on the academic staff at Tel Aviv University. Education: MD, Technion; Pediatrics residency, Assaf HaRofeh; Pediatric Hemato-Oncology fellowship, Sheba.

Prof. Elad Jacoby, MD, heads the Pediatric Cell Therapy Center at Sheba Medical Center. He is the Medical Director of the Advanced Biotherapy Center. He is a pioneer of pediatric CAR T‑cell therapy in Israel. He led one of the first national leukemia programs. He has almost 20 years of clinical and research experience.

He specializes in CAR T‑cell therapy, bone marrow and stem cell transplantation, and high‑risk pediatric leukemias and lymphomas. He leads international clinical trials and has authored over 240 publications. His collaborations include Johns Hopkins Hospital and the U.S. National Cancer Institute. He is an Associate Professor at Tel Aviv University. He received his MD from Tel Aviv University, completed residency at Sheba Medical Center, and fellowships at Johns Hopkins and the National Cancer Institute. He is board‑certified in Pediatrics and in Pediatric Hematology and Oncology. He serves on the IBFM CAR T‑Cell Taskforce and the Sheba Institutional Review Board. He leads the integration of CAR T‑cell therapy with transplantation.

A Professora Zila Zuckerman é especialista em hematologia e transplantologia no Rambam Medical Center.

• Especialista no tratamento de leucemia linfoblástica aguda
• Especializada em transplantologia para distúrbios sanguíneos
• Professora com vasta experiência académica e clínica

Chefe de Hematologia no Hadassah Medical Center – A Professora Ben-Yehuda foi pioneira em terapia génica e transplantes de medula óssea para leucemia linfoblástica aguda.

• Formada no Memorial Sloan-Kettering Cancer Center em Nova Iorque
• Primeira mulher reitora da Faculdade de Medicina de Hadassah
• Especializada em diagnóstico molecular e imunologia
• Vencedora do prémio Healing with the Heart pelo cuidado excecional ao paciente

Reconhecido pela Forbes como um dos melhores médicos em 2018 – o Dr. Stepensky realizou mais de 3.500 transplantes de medula óssea no Hadassah Medical Center.

• 20 anos de especialização em transplantes de medula óssea pediátricos
• Foco em doenças raras de cancro do sangue em crianças
• Conhecido entre os pacientes como 'aquele que transplanta a vida'
• Liderar uma unidade de hematologia pediátrica dedicada

O Dr. Ofer Spielberg é um onco-hematologista especializado, com foco em cancros do sangue, como a leucemia.

• Trabalhar no Assuta Medical Center
• Experiência em onco-hematologia, a área dedicada aos cancros do sangue
• Fornecer tratamento direcionado para a leucemia linfoblástica aguda